No doubt that EBOS just bought the contract for Year 1 and happy with low margins going forward. Must have a lot of spare capital. Their next step will be find a cheap Chinese manufacturer to reduce costs further. Good luck with the regulatory issues, TGA and reputational damage should they have any issues with their drugs.
SIG CEO stated that he would have had to half the profit on the CWH contract. So makes complete sense to find multiple higher margin contracts/businesses to de-risk business.
Ann: Change of Director's Interest Notice, page-76
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SIG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.43 |
Change
0.485(24.9%) |
Mkt cap ! $2.300B | |||
| Open | High | Low | Value | Volume |
| $2.52 | $2.70 | $2.32 | $138.1M | 55.83M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 123400 | $2.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.44 | 1365 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| SIG (ASX) Chart |
